Inactive Instrument
Curable. Inc. Stock
Stocks
A086460
KR7086460003
Biotechnology & Medical Research
| 1 day | -17.54% |
| Manager | Title | Age | Since |
|---|---|---|---|
Jin-Chan Kim
CEO | Chief Executive Officer | 57 | - |
Tae-Yong Cho
CEO | Chief Executive Officer | 61 | 29/04/2025 |
Han-Kyung Kim
AUD | Comptroller/Controller/Auditor | 52 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Jae-Won Yang
BRD | Director/Board Member | 56 | - |
Sang-Rae Lee
BRD | Director/Board Member | 54 | - |
Jong-Seon Lee
BRD | Director/Board Member | 55 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -17.54% | -84.18% | - | - | 4.64K | ||
| -0.62% | -1.87% | +46.31% | +56.99% | 63.77B | ||
| +0.35% | +3.20% | +14.92% | +84.55% | 56.37B | ||
| +0.53% | +1.96% | +15.37% | +106.81% | 54.62B | ||
| -2.81% | -4.31% | +23.50% | +50.90% | 44.06B | ||
| -0.33% | -1.93% | +20.15% | +98.45% | 42.11B | ||
| +0.55% | +2.31% | +224.97% | +942.56% | 41B | ||
| +3.27% | +47.96% | +112.67% | +96.48% | 34.92B | ||
| +1.22% | -1.44% | +14.89% | +47.15% | 32.82B | ||
| +0.89% | +20.55% | -42.03% | +373.03% | 24.7B | ||
| Average | -1.45% | +7.54% | +47.86% | +206.32% | 43.82B | |
| Weighted average by Cap. | +0.18% | +5.44% | +48.50% | +186.13% |
Employees
-
















